Q4 2024 · 13F-HR
M28 Capital Management LPholdings as filed
Filed 2025-02-13 · accession 0000902664-25-000931
$101.9M
Reported value
11
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $70.1M | 68.8% | 5,664,548 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $4.9M | 4.78% | 161,600 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $4.8M | 4.76% | 385,680 | Common | SOLE |
| 00534A102 | IVVD | INVIVYD INC | $4.1M | 4.02% | 9,248,250 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $4.0M | 3.92% | 110,400 | Common | SOLE |
| 35168W103 | GUTS | FRACTYL HEALTH INC | $3.8M | 3.75% | 1,856,117 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $3.3M | 3.27% | 121,200 | Common | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $2.7M | 2.65% | 1,019,498 | Common | SOLE |
| 231269309 | CRIS | CURIS INC | $1.6M | 1.57% | 521,059 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $1.3M | 1.25% | 185,100 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $1.3M | 1.24% | 67,400 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.